Literature DB >> 23593581

Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.

Urmila M Aswar1, Padmaja P Kalshetti, Suhas M Shelke, Sharad H Bhosale, Subhash L Bodhankar.   

Abstract

OBJECTIVE: To study the derivatives of 1,2,4-triazino[5,6-b]indole-3-thione for antidepressant activity in olfactory bulbectomized (OBX) rats. Out of various derivatives tested for acute tail suspension test, the two derivatives showing prominent action were selected for bilateral olfactory bulbectomy model of chronic depression in rats.
METHODS: The sub acute effects of 14-day oral pretreatment of two derivatives labeled as 3a (70 mg/kg) and 3r (70 mg/kg), imipramine (20 mg/kg), fluoxetine (30 mg/kg) and moclobemide (15 mg/kg) were evaluated on bilateral bulbectomy induced rise in body weight, hyperphagia, hyperactivity, and on sexual dysfunction. The serum sodium concentration, body temperature, and heart rate were also recorded.
RESULTS: The derivatives 3a and 3r showed reversal of drop in body weight, reversed OBX induced hyperactivity, normalized body temperature, heart rate, and serum sodium concentration. In elevated maze test, moclobemide, 3a, 3r treatment significantly reduced time spent in open arm as compared to OBX rats. 3a and 3r also improved sexual behavior parameters.
CONCLUSIONS: The present study shows promising antidepressant action and provides a proof of concept for the chronic treatment of 3a, 3r to treat depression.

Entities:  

Keywords:  1,2,4 -triazino-[5,6-b]indole-3-thione; Antidepressant activity; Olfactory bulbectomy

Mesh:

Substances:

Year:  2012        PMID: 23593581      PMCID: PMC3621477          DOI: 10.1016/S2221-1691(13)60012-X

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  26 in total

1.  Increasing heterogeneity in the organization of synaptic inputs of mature olfactory bulb neurons generated in newborn rats.

Authors:  Wolfgang Kelsch; Shuyin Sim; Carlos Lois
Journal:  J Comp Neurol       Date:  2012-04-15       Impact factor: 3.215

2.  Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.

Authors:  Michelle Roche; Andrew Harkin; John P Kelly
Journal:  Neuropsychopharmacology       Date:  2006-11-22       Impact factor: 7.853

3.  Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.

Authors:  Rajkumar Ramamoorthy; Mahesh Radhakrishnan; Minasri Borah
Journal:  Behav Pharmacol       Date:  2008-02       Impact factor: 2.293

4.  The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.

Authors:  M E Breuer; J S W Chan; R S Oosting; L Groenink; S M Korte; U Campbell; R Schreiber; T Hanania; E M S Snoeren; M Waldinger; B Olivier
Journal:  Eur Neuropsychopharmacol       Date:  2008-09-11       Impact factor: 4.600

Review 5.  New approaches to antidepressant drug discovery: beyond monoamines.

Authors:  Olivier Berton; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

Review 6.  Cost-of-illness studies of depression: a systematic review.

Authors:  Melanie Luppa; Sven Heinrich; Matthias C Angermeyer; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  J Affect Disord       Date:  2006-09-06       Impact factor: 4.839

7.  Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.

Authors:  Akiyoshi Saitoh; Kazumasa Yamaguchi; Yoshimi Tatsumi; Hiroyasu Murasawa; Akiko Nakatani; Noritaka Hirose; Misa Yamada; Mitsuhiko Yamada; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2007-02-22       Impact factor: 4.530

8.  Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

Authors:  Saba Moussavi; Somnath Chatterji; Emese Verdes; Ajay Tandon; Vikram Patel; Bedirhan Ustun
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 9.  The molecular neurobiology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

Review 10.  Treatment of bipolar depression: an update.

Authors:  Konstantinos N Fountoulakis; Heinz Grunze; Panagiotis Panagiotidis; George Kaprinis
Journal:  J Affect Disord       Date:  2007-11-26       Impact factor: 4.839

View more
  3 in total

1.  Design, Synthesis, and Biological Evaluation of 1,2,3-Triazole-Linked Triazino[5,6-B]Indole-Benzene Sulfonamide Conjugates as Potent Carbonic Anhydrase I, II, IX, and XIII Inhibitors.

Authors:  Krishna Kartheek Chinchilli; Andrea Angeli; Pavitra S Thacker; Laxman Naik Korra; Rashmita Biswas; Mohammed Arifuddin; Claudiu T Supuran
Journal:  Metabolites       Date:  2020-05-15

2.  New Triazinoindole Bearing Benzimidazole/Benzoxazole Hybrids Analogs as Potent Inhibitors of Urease: Synthesis, In Vitro Analysis and Molecular Docking Studies.

Authors:  Sundas Mumtaz; Shahid Iqbal; Mazloom Shah; Rafaqat Hussain; Fazal Rahim; Wajid Rehman; Shoaib Khan; Obaid-Ur-Rahman Abid; Liaqat Rasheed; Ayed A Dera; Hanan A Al-Ghulikah; Sana Kehili; Eslam B Elkaeed; Hamad Alrbyawi; Mohammed Issa Alahmdi
Journal:  Molecules       Date:  2022-10-04       Impact factor: 4.927

3.  Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking.

Authors:  Muhammad Taha; Foziah J Alshamrani; Fazal Rahim; Shawkat Hayat; Hayat Ullah; Khalid Zaman; Syahrul Imran; Khalid Mohammed Khan; Farzana Naz
Journal:  Molecules       Date:  2019-10-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.